|
市場調查報告書
大型製藥企業未來展望（至2016年）
Big Pharma Company Outlook to 2016
| 出版商 |
Datamonitor |
| 出版日期 |
2011年11月 |
商品編碼 |
229443 |
| 內容資訊 |
英文 Pages: 50 |
| 價格 |
|
|
大型製藥企業未來展望（至2016年） 是由出版商Datamonitor在2011年11月所出版的。
這份英文市場調查報告書包含Pages: 50 價格從美金3800起跳。
本報告針對全球大型製藥企業未来展望進行分析，提供未來6年業績預測、生産・開發・成長策略預測等內容，目錄介紹如下。
摘要整理
- 主要分析結果
- 企業比較分析概要
- 至2016年未来展望
介紹
策略考察
大型製藥企業至2016年未来展望
- 主要分析結果
- 概要
- 處方藥販售量（2004∼16年）
- 市場環境（2010∼16年）
- 企業分析
- 新發售/主力商品/專利到期分析
- 治療領域分析
- 分子種類分析
附錄
Description
Introduction
This analysis examines the outlook for companies in Datamonitor's Big Pharma peer set. The report encompasses insight into key strategic themes across the group of companies and identifies sales trends using 6-year prescription pharmaceutical sales forecasts for all the companies covered.
Features and benefits
- Gain insight into Big Pharma companies strategic outlook across the next 6 years
- Analyze sales forecasts by company, therapy area, lifecycle stage, and molecule type.
Highlights
- Strategic insight into the prospects for Big Pharma companies over the next six years. Picking out key trends across the companies and comparing performance using a variety of cuts of forecast sales.
Your key questions answered
- Benchmark companies outlook against key rivals across Datamonitor's Big Pharma peer set
- Assess how - based on organic growth projections - Novartis will be positioned as the industry leading prescription pharma player by 2016
TOC
Executive Summary
- Key findings
- Overview of the Big Pharma peer set
- Big Pharma prescription sales performance, 2004-16
- The Big Pharma company outlook to 2016
INTRODUCTION
- Data sourcing
- Further reading
STRATEGIC INSIGHT
- Big Pharma growth rate to slow significantly over 2010-16
BIG PHARMA OUTLOOK TO 2016
- Key findings
- Overview of Big Pharma to 2016
- Big Pharma prescription pharma sales performance, 2004-16
- Big Pharma landscape, 2010-16
- Big Pharma company analysis
- Big Pharma launch/core/expiry analysis
- Big Pharma therapy area analysis
- Big Pharma molecule type analysis
APPENDIX
- References
- Exchange rates
|
